
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
Total number of projects: 2
As coordinator: 1
As participant: 0
Sole participant: 1
Coordinator / Participant Ratio: *
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2020 | 4.922.202 | 0 | 1.795.840 | 2 | ||
| Institution: | Projects [No]: |
|---|---|
| ACADEMIC MEDICAL CENTRE AMSTERDAM | 1 |
| KABS LABORATORIES INC KABS | 1 |
| ORION SANTE SARL | 1 |
| STICHTING VUMC | 1 |
Total number of partners: 4
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 4
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2020-10-01 | First effective pharmacotherapy for ARDS to lower mortality and improve quality of life of patients. | Impentri | coordinator | 1.259.239 | 1 |
| 2020-07-01 | Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS). | Impentri | coordinator | 3.662.963 | 5 |